Skip to Content

Join the 'Candida' group to help and get support from people like you.

Candida News

FDA Approves Merck’s Noxafil Delayed-Release Tablets

Posted 26 Nov 2013 by Drugs.com

WHITEHOUSE STATION, N.J., Nov. 26, 2013--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Noxafil (posaconazole) 100 mg delayed-release tablets. Noxafil delayed-release tablets are a new formulation with a loading dose of 300 mg (three 100 mg delayed-release tablets) twice daily on the first ...

Ask a Question